GEIST:UPC Searchengine

ORD_598363/2023

Regeneron Pharmaceuticals Inc. v. Amgen Inc.

Datum
2024-07-16
Kammer
Munich (DE) Central Division - Section
Verfahrensart
Counterclaim for revocation
Sprache
EN

Metadaten

Fall-IDORD_598363-2023-855a61408692
Aktenzeichen
RegisterzeichenORD_598363/2023
EntscheidungsreferenzORD_598363/2023
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 53

1 DECISION of the Court of First Instance of the Unified Patent Court Central division (Section Munich) delivered on 16 July 2024 concerning EP 3 666 797 B1 HEADNOTES: 1. When interpreting a patent claim, the person skilled in the art does not apply a philological understanding, but determines the technical meaning of the terms used with the aid of the description and the drawings. From the function of the individual features in the context of the patent claim as a whole, it must be deduced which technical function these features actually have individually and as a whole. The patent description may represent a patent´s own lexicon. 2. A claimed invention is to be conside red the “same invention” as meant in Article 87 EPC (priority right) if the skilled person can derive the subject-matter ...